Sign in
TerminatedPhase 4

Early Antibiotics After Aspiration in ICU Patients

Key facts

Who runs it
UConn Health
Where
Farmington, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 4
People taking part
5 people enrolled
Started
30 Nov 2021
Ended
12 Apr 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Ceftriaxone
  • Amoxicillin clavulanic acid
  • Cefepime
  • Vancomycin
  • Levofloxacin
Record updated
30 December 2025
Why it stopped
Under-enrollment

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Admitted to the ICU within the last 24 hours, or with a witnessed aspiration event in the last 24 hours while in the ICU
  • Radiographic findings on chest x-ray or CT deemed by the treating ICU team to be consistent with aspiration (e.g. dependent infiltrates or intraluminal airway debris)
  • Clinical history consistent with possible aspiration (e.g. cardiac arrest, found unconscious, or with a witnessed aspiration event)

Who cannot take part

  • Already received 3 or more doses of any antibiotic since hospital presentation, unless the last dose was greater than 1 week before enrollment
  • Currently participating in other trials using investigational drugs or interventions
  • Requires antibiotic therapy for the treatment of other infections
  • White blood cell count: ≥ 11.0
  • Patient "comfort measures only" at time of screening
  • Currently pregnant
  • Currently a prisoner
  • The consenting party (patient or their legally authorized representative) is unable to understand or read English at a fifth-grade level
  • 2 or more of the following are present at the time of screening:
  • Temperature ≥ 38.0C (100.4F)
  • Purulent secretions
  • S/F (pulse oximetry saturation to FiO2) ratio ≤ 215

Where in United States

  • UConn Health / John Dempsey HospitalFarmington, United States

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.

The 2 groups in the trial

  • AntibioticsTreatment being tested

    5 days of empiric antibiotics selected from a guideline-appropriate regimen. Alternate agents may be selected by the treating team if allergies or other patient factors mandate, but are still recommended for a 5 day course. Supportive care including oxygen and ventilation can be offered ad libitum. Options include ceftriaxone, Augmentin, cefepime, vancomycin, levofloxacin.

    Treatment: Ceftriaxone, Amoxicillin clavulanic acid, Cefepime, Vancomycin, and Levofloxacin

  • ControlNo study treatment, for comparison

    No initial antibiotic therapy unless clinical picture changes or worsens. Supportive care including oxygen and ventilation can be offered ad libitum.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Antibiotic Prophylaxis in Critically Ill Patients After Suspected Aspiration
Record updated
30 December 2025